Skip to main content
. 2017 Jun 22;12(6):e0179429. doi: 10.1371/journal.pone.0179429

Table 3. Descriptive characteristics and levels of moderate-to-vigorous intensity physical activity and sedentary time in children with chronic respiratory diseases.

Reference* Place and publication year Sample group
n, male% and age (yrs)
Control group
n, male% and age (yrs)
Measurement Accelerometry methods MVPA Sedentary time
Aznar et al [36] Spain, 2014 n: 47, (51% male) n: 39; (59% male) Actigraph GT3X, worn on right hip for 7 days during waking hours Epoch = 15s, Evenson cut-point [30] Patients mean 44 (SD 28) min/day Patients mean 362 (SD 67) min/day
Age: mean 12.0 (SD 3.0) Age: mean 12.0 (SD 2.0) MVPA ≥ 2296 cpm Control group mean 54 (SD 15) min/day Control group mean 484 (SD 85) min/day
Sedentary time < 100 cpm MVPA significantly lower in patient (p < 0.02) Sedentary time was lower in patients (p < 0.001)
2% of patients and 34% of control group achieved an average 60 min/ day of MVPA
Kilbride et al [37] Ireland, 2012 n: 16, (56% male) n: 99, (48% male) RT3 worn for 3 days Epoch and MVPA cut-points not clearly reported Patients mean boys 15 (SD 3); girls 16 (SD 3) min/day N/A
Age: range 10–12 Age: range 10–12 Sedentary time = 0–99cpm Control group mean boys 23 (SD 6); girls 15 (SD 3) min/day
MVPA similar in patients and control group
All patients failed to meet an average of 60 minutes/day MVPA
Smith et al [38] Germany, 2016 n: 94, (56% male) n: 590, (40% male) Actigraph GT3X, worn on right hip for 7 days during waking hours Epoch = 60s. Freedson cut-point [35] Patients mean boys 41 (35) 11, 89; girls 43 (36) 14, 71 min/day N/A
Age: mean 15.6 (SD 0.5) Age: mean 15.7 (SD 0.5) Control group mean boys 46 (42) 19, 89; girls 38 (34) 13, 70 min/day
Tsai et al [39] USA, 2012 n: 27, (70% male) n: 27, (59% male) actigraph (Actiwatch 64 MM), worn non-dominant wrist for 7 days during waking hours Epoch = 60s Patients mean 265 (SD 83) min/day Patients mean 87 (SD 48) min/day
Age: range 9–11 Age: range 9–11 MVPA ≥ 700 cpm Control group mean 308 (SD 97) min/day Control group mean 77 (SD 27) min/day
Sedentary time = 0–49 cpm MVPA similar in patients and control group (p = 0.09) Sedentary time difference not significant (p = 0.3)
Patients and control group achieved an average of 60 min per day of MVPA
Vahlkvist et al [40] Denmark, 2010 n: 55 n: 154 RT3 worn for 4 weeks during 24 h a day Epoch and cut-points not clearly reported Patients mean of 32 (95% CI 5) min/day Patients mean 1270 (95% CI 15) min/day
Age: range 6–14 Age: range 6–14 Control group mean 34 (95% CI 3) min/day Control group mean 1261 (95% CI 9) min/day
MVPA similar in patients and control group Sedentary time was similar in patient and control group
Patients and control group failed to achieve an average of 60 min per day of MVPA
Van- Gent et al [41] Netherlands, 2007 n: 81, (58% male) n: 202, (50% male) Pam AM 100, worn on hip for 5 days during waking hours Epoch = 60s Patients mean 99 (95%, CI 80, 118) min/day N/A
Age: mean 9.4 (SD 0.8) Age: mean 9.4 (SD 0.7) MVPA cut-points not clearly reported Control group mean 98 (95%, CI 85, 106) min/day
MVPA similar in patients and control group
Patients and control group achieved an average of 60 min per day of MVPA
Yiallouros et al [42] Cyprus, 2015 n: 36, (64% male) n: 99, (60% male) Actigraph worn on wrist for 7 days during waking hours Epoch not clearly reported Patients mean 15 (95% CI 10–21) min/day Patients mean 939 (95% CI 915–963) min/day
Age: range 8–9 Age: range 8–9 MVPA > 3200 cpm Control group mean 16 (95% CI 14–19) min/day Control group mean 927 (95% CI 915–938) min/day
Sedentary time < 100 cpm Similar in patients and control group Similar in patients and control group

cpm: counts per minutes; MVPA: moderate-to-vigorous physical activity; n: Number; S: Second; Data are expressed as mean (SD) unless otherwise in Smith et al [38]: MVPA calculated as mean (Geometric mean) 5th, 95th percentile, and Yiallouros et al [42]: MVPA Calculated as geometric means (95% CI) in min/day.; Freedson MVPA cutpoint [35] calculated using the following equation: METS = 2.757 + (0.0015 x counts/min)–(0.08957 x age (yr))–(0.000038 x counts/min x age (yr))

*Studies are recruited healthy control participants and measured MVPA and ST in the same way as in their patient participants and at the same time(referred to here as studies with control group).